General contact

Head Office
Novartis International AG
CH-4002 Basel

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)


Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel

+41 61 324 79 44


Global Oncology Media Relations
Denise Brashear
Novartis Oncology Global Public Relations

+1 862 778 7336

Novartis Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

pane 4 content

This site is not intended for U.S. residents.

Patient-Inspired Solutions

Patient-inspired solutions provide more than medicine

Treating cancer and related diseases is about supporting patients with more than medicine:

  • Disease-specific programs provide comprehensive support to patients, helping to ensure the best outcome in collaboration with providers and payers.
  • Our innovative portfolio of access-to-treatment projects adapts to patient needs, products, partners and countries.

Connecting with patient groups and others in the community helps us understand and reflect patient needs. Working together, we have established a variety of disease alliances aimed at supporting the varied needs of all those involved in the drug treatment process. Our track record of innovative access programs is unmatched in the industry. With the addition of the GSK oncology product portfolio, we will develop new connections and leverage existing relationships to improve outcomes and the availability of medicines.

"Together, we make innovation happen".